|
|||||
|
|
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group |
|
| Authors: | Mark Bustoros Efstathios Kastritis Romanos Sklavenitis-Pistofidis Chia-Jen Liu Kalvis Hornburg Nikolaos Kanellias Geon Kim David Liu Maria Gavriatopoulou Catherine R. Marinac Maria Roussou Magdalini Migkou Kimberly Noonan Kaitlen Reyes Bradley Rivotto Carl Jannes Neuse Dimitrios C. Ziogas Jacob Laubach Evangelos Terpos Kenneth C. Anderson Paul G. Richardson Irene M. Ghobrial Meletios A. Dimopoulos |
| Affiliation: | 1. Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts;2. Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece;3. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts;4. Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts;5. Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts |
| Abstract: | |
| Keywords: | |